Sildenafil Versus Placebo in Chronic Heart Failure

PHASE3UnknownINTERVENTIONAL
Enrollment

75

Participants

Timeline

Start Date

March 31, 2013

Primary Completion Date

June 30, 2018

Study Completion Date

December 31, 2019

Conditions
Heart FailurePulmonary Hypertension
Interventions
DRUG

Sildenafil

PDE-5 Inhibitor

DRUG

Placebo

Placebo for sildenafil 40mg x 3 daily

Trial Locations (6)

4011

Stavanger University Hospital, Stavanger

20097

San Donato Hospital, Milan

34362

Lady Davis Carmel Medical CEnter, Haifa

49100

Rabin Medical Center, Petah Tikva

HU16 5JQ

Castle Hill Hospital, Hull

S5 7AU

Northern General Hospital, Sheffield

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Pfizer

INDUSTRY

lead

Helse Stavanger HF

OTHER_GOV

NCT01616381 - Sildenafil Versus Placebo in Chronic Heart Failure | Biotech Hunter | Biotech Hunter